新一代医用关键聚合物材料SEBS应用推广会召开
巴陵石化公司组织召开新一代医用关键聚合物材料SEBS应用推广会。公司经理在致辞中重点介绍了公司持续推进技术创新的有关情况。他说，在努力建设世界一流锂系聚合物生产及研发基地的进程中，公司锂系聚合物年总产能已达28万吨，其中具有自主知识产权的SEBS装置年产达4万吨，为国内最大，产品在各领域得到日益广泛应用。巴陵公司将认真采纳各方专家意见和建议，强化“产、学、研、用”结合，稳定生产高品质的医用SEBS产品，以其国产化造福大众生活。
近年来，随着人们生活水平和国家环保要求的不断提高，SEBS特种化、高端化成为行业发展的必然趋势。性能优越的SEBS是替代软质PVC（聚***乙烯）的最佳材料，在医疗器械领域可制作一次性输液器、一次性注射器的密封胶圈、输液瓶盖、止血带、各种引流管、输液袋及创口贴等，应用前景广泛。长期以来，医用SEBS生产技术被美国和日本公司垄断，严重影响了我国相关产业的发展。
新一代医用关键聚合物材料SEBS成功研发，是巴陵石化“产学研”结合创新的成功范例。今后将做好医用SEBS产品产业化及工业应用、市场开拓等工作。 研讨会上，与会专家及有关医疗器械生产厂家负责人一致积极评价公司在新一代医用SEBS国产化技术创新方面的阶段成果，希望公司在提高产品稳定性、加工性能、粘结性能等方面进一步下功夫，积极做好产品的生物性评价、药物性评价和安全性评价等工作，推进巴陵牌医用SEBS产品在医疗器械行业的应用进程。
A new generation of medical polymer materials critical to promote the application will be held SEBS
Baling Petrochemical Company held the key to a new generation of medical polymer materials will promote the application of SEBS. Company manager in his speech highlighted the company continued to promote the technological innovation of the situation. He said, in an effort to build a world-class lithium polymer production and R & D base in the process, the company has reached annual capacity lithium polymer 280,000 tons, of which have independent intellectual property rights SEBS unit annual output of 40,000 tons, as the largest domestic product in various fields have been increasingly widely used. Baling parties will heed expert advice and recommendations to strengthen the "production, learning and research, with a" combination of stable production of high-quality medical SEBS products, its localization benefit of the public life.
In recent years, with the continuous improvement of people's living standards and national environmental requirements, SEBS specialty, high-end become the inevitable trend of development of the industry. SEBS is an alternative to the superior performance of soft PVC (polyvinyl chloride) is the best material in the field of medical devices can be made disposable infusion set, disposable syringes sealing gasket, infusion bottle, a tourniquet, a variety of drainage tubes, broad application prospects wound infusion bags and stickers. For a long time, medical SEBS production technology is monopolized American and Japanese companies, has seriously affected the development of the relevant industries.
Generation of key medical polymer materials SEBS successfully developed, is a successful example of Baling Petrochemical "research" combines innovation. SEBS future will make medical products industry and industrial applications, marketing and so on.
At the seminar, experts and related medical device manufacturers responsible consistent positive results of the evaluation stage in a new generation of medical SEBS domestic technology innovation, the company hopes to further improve product stability under processing performance, bonding properties, etc. effort, actively carry out biological evaluation, drug evaluation and safety evaluation work products, promote Baling licensing of medical products in the medical device industry SEBS application process.
|
